Sarah Hughes

As remote production booms, a major security flaw has emerged. Backlight's Iconik now integrates Castlabs tech to protect media from the very first frame.

Acurx Pharma's new drug, ibezapolstat, offers a novel weapon against deadly infections like C. diff by sparing good bacteria. Is this the breakthrough we need?

A new AI platform promises to slash drug development red tape. But can it overcome the industry’s deep-rooted challenges of privacy, trust, and integration?

SPC Nickel is betting big on Nunavut's Muskox Intrusion, using advanced tech to hunt for a Norilsk-scale prize. But in the Arctic, the real tests lie beyond the bedrock.

A chronic shortage of poll workers threatens American democracy. Now, a strategic alliance is deploying one of the nation’s most trusted groups—veterans—to fill the gap.

Enterprises have poured billions into data and AI, but many still struggle to turn insights into action. A new suite of tools aims to fix the disconnect.

As the complex Non-QM mortgage market booms, one lender is giving its partners a free AI tool. It’s a glimpse into a future where algorithms decide who gets a loan.

In Pensacola, historic homes are more than architecture; they're a story. But who gets to tell that story, and what happens when heritage meets marketing?

The crypto exchange touts democratized access to elite investments. But beneath the hype of Pre-IPO tokens lies a world of regulatory risk and unclear ownership.

As the Port of Trois-Rivières posts a sharp drop in cargo, its leaders are betting a $312M overhaul will secure its future. But is it a sound investment?

For decades, patients with advanced chondrosarcoma had no options. Now, a new drug's journey to the FDA offers a lifeline and a lesson in medical neglect.

Phase 1 data for Marea Therapeutics’ MAR002 suggests a potential new era for acromegaly treatment, promising better control with far fewer injections.

The 18th Straits Forum promotes 'people-to-people' ties, but Taipei calls it a political ploy. What's at stake for the people caught in between?

SKHTU Exchange touts a localized push for a Malaysian crypto license. But as it courts one of Asia's top regulators, a trail of questionable claims casts a shadow.

Carol Craig, a trailblazing space entrepreneur, just joined the board of an oil company drilling in the Arctic. Is this tech-fueled innovation or a final, desperate fossil fuel gambit?

Hisense's dazzling World Cup pop-up at Hudson Yards offers fans a tech-fueled fantasy. But beneath the surface lies a calculated play for market dominance.

A new CFD broker hit $300B in its first year by targeting emerging markets. But its rapid growth reveals a strategy built on speed, risk, and regulatory gaps.

As the World Cup descends on Kansas City, Walgreens steps beyond selling snacks, becoming a crucial healthcare lifeline for global fans. Is this the future of event support?

In memory of her daughter Elora, a mother's foundation joins a global research network, turning personal tragedy into a collaborative fight against a rare cancer.

As Pride Month unfolds, a look inside the complex world of surrogacy for gay men, where medical pioneers and community advocates are rewriting the rules of parenthood.